XML 53 R41.htm IDEA: XBRL DOCUMENT v3.21.2

SEGMENT INFORMATION (Tables)

6 Months Ended

Jun. 30, 2021

Segment Reporting [Abstract]

Schedule of segment revenues and profit

Segment revenues and profits were as follows:

			Three Months Ended June 30,												Six Months Ended June 30,
(in millions)			2021						2020						2021						2020
Revenues:
Bausch + Lomb			$	934					$	677					$	1,815					$	1,552
Salix			516						404						988						881
International Rx			313						249						619						540
Ortho Dermatologics			137						117						278						248
Diversified Products			200						217						427						455
			$	2,100					$	1,664					$	4,127					$	3,676
Segment profits:
Bausch + Lomb			$	213					$	124					$	452					$	387
Salix			370						289						697						608
International Rx			103						75						212						173
Ortho Dermatologics			61						38						131						85
Diversified Products			140						154						311						321
			887						680						1,803						1,574
Corporate			(199)						(145)						(380)						(301)
Amortization of intangible assets			(360)						(436)						(717)						(872)
Goodwill impairments			—						—						(469)						—
Asset impairments			(47)						(1)						(195)						(15)
Restructuring, integration and separation costs			(9)						(7)						(21)						(11)
Other expense, net			(542)						(118)						(512)						(154)
Operating (loss) income			(270)						(27)						(491)						221
Interest income			2						2						4						9
Interest expense			(364)						(385)						(732)						(781)
Loss on extinguishment of debt			(45)						(27)						(50)						(51)
Foreign exchange and other			7						—						8						(13)
Loss before benefit from income taxes			$	(670)					$	(437)					$	(1,261)					$	(615)

Schedule of revenues by segment and product category

Revenues by segment and product category were as follows:

(in millions)			Bausch + Lomb						Salix						International Rx						Ortho Dermatologics						Diversified Products						Total
			Three Months Ended June 30, 2021
Pharmaceuticals			$	134					$	514					$	67					$	59					$	164					$	938
Devices			397						—						—						73						—						470
OTC			329						—						32						—						2						363
Branded and Other Generics			68						—						206						—						31						305
Other revenues			6						2						8						5						3						24
			$	934					$	516					$	313					$	137					$	200					$	2,100
			Three Months Ended June 30, 2020
Pharmaceuticals			$	96					$	403					$	55					$	70					$	161					$	785
Devices			220						—						—						42						—						262
OTC			295						—						20						—						2						317
Branded and Other Generics			57						—						161						—						55						273
Other revenues			9						1						13						5						(1)						27
			$	677					$	404					$	249					$	117					$	217					$	1,664
			Six Months Ended June 30, 2021
Pharmaceuticals			$	259					$	984					$	126					$	124					$	341					$	1,834
Devices			779						—						—						145						—						924
OTC			645						—						57						—						4						706
Branded and Other Generics			119						—						418						—						78						615
Other revenues			13						4						18						9						4						48
			$	1,815					$	988					$	619					$	278					$	427					$	4,127
			Six Months Ended June 30, 2020
Pharmaceuticals			$	234					$	880					$	121					$	146					$	343					$	1,724
Devices			561						—						—						93						—						654
OTC			616						—						46						—						4						666
Branded and Other Generics			125						—						349						—						105						579
Other revenues			16						1						24						9						3						53
			$	1,552					$	881					$	540					$	248					$	455					$	3,676

Schedule of revenue attributed to a geographic region

Revenues are attributed to a geographic region based on the location of the customer and were as follows:

			Three Months Ended June 30,												Six Months Ended June 30,
(in millions)			2021						2020						2021						2020
U.S. and Puerto Rico			$	1,216					$	1,009					$	2,378					$	2,221
China			119						79						229						137
Canada			87						67						163						157
Egypt			68						58						134						116
Poland			71						37						133						111
Mexico			56						48						125						89
Japan			55						48						115						102
France			56						42						110						89
Germany			28						32						70						76
Russia			33						24						64						57
United Kingdom			27						14						52						37
Spain			23						12						42						32
South Korea			20						16						40						33
Other			241						178						472						419
			$	2,100					$	1,664					$	4,127					$	3,676

Schedule of customers that accounted for 10% or more of total revenue

Customers that accounted for 10% or more of total revenues were as follows:

			Six Months Ended June 30,
			2021						2020
AmerisourceBergen Corporation			17%						18%
McKesson Corporation (including McKesson Specialty)			16%						17%
Cardinal Health, Inc.			12%						13%

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration